Abstract

Bone marrow lesions (BMLs) on MRI are typically subchondral in location, however, a proportion occur at knee ligament attachments and also include a cyst-like component. Our aim was to determine whether the volume of BML subtypes and synovial tissue volume (STV) was associated with symptoms in symptomatic knee OA. Images were acquired in a sub-sample who had taken part in a randomised trial of vitamin D therapy in knee OA (UK-VIDEO). Contrast-enhanced (CE) MRI was performed annually. In those who had ≥1 follow-up and a baseline scan (N=50), STV and BML volume was assessed. BMLs were categorised by location and by the presence/absence of a cyst-like component. WOMAC was assessed annually. We used fixed-effects panel-regression modelling to examine the association between volume and symptoms. There was no association between knee pain and total subchondral BML volume (b=0.3 WOMAC units, 95% CI -0.3 to 1.0) or total ligament-based BML volume (b=1.9, 95% CI -1.6 to 5.3). The volume of subchondral BMLs with a cyst-like component was not associated with pain (b=0.8, 95% CI -0.5 to 2.1) however, the volume of the cyst-like component itself was associated with pain (b=51.8, 95% CI 14.2 to 89.3). STV was associated with pain (b=2.2, 95% CI 0.6 to 3.7). The volume of the cyst-like component from subchondral BMLs with a cyst-like component was associated with knee pain. BML location, however, did not influence symptoms. STV was also associated with knee symptoms.

Highlights

  • Our data suggest that the volume of the cyst-like component

  • itself from subchondral BMLs with cyst-like component on CE MRI are associated with pain in men and women

  • In this study BML location did not influence the occurrence of knee symptoms

Read more

Summary

Methods

Subjects included in the analysis were participants of the UK VIDEO trial (ISRCTN94818153); a 3-year multicentre, randomised, doubleblind, placebo-controlled trial which examined the effect of vitamin D therapy (800 IU/daily) on radiographic joint space narrowing (JSN) in men and women with symptomatic knee OA14. Participants were randomised to either oral vitamin D (800 IU/daily) or matching placebo, by study site, using computer-generated number allocation in a 1:1 ratio. A subsample of subjects at one centre (Southampton) had MRIs acquired at baseline and annually until the end of the study. 50 participants were included in the current analysis - comprising those subjects randomised to both vitamin D and placebo who had; i) a baseline sagittal T1-weighted (T1-w) fat suppressed (FS) CE MRI and at least one other CE scan over the first 2 years of the study. In cases of bilateral knee OA, the knee with the smallest joint space width was used

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call